Evidence map›Paper›PMID 40437998›Full record

ReviewImmunotherapy2025

Dietary impacts on prostate cancer immunotherapy.

Loan D Duong, Xin Lu

Abstract readReview
In one paragraph

Review in Immunotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Loan D DuongDepartment of Biological Sciences, Boler-Parseghian Center for Rare Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN, USA.
Xin LuDepartment of Biological Sciences, Boler-Parseghian Center for Rare Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN, USA.

Funding

Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin EffectorR01CA248033 · NCI · UNIVERSITY OF NOTRE DAME · PI LU, XIN · 2020 to 2024
$1.8M
Immunosuppression and Metabolic Rewiring in Tumor-infiltrating NeutrophilsR01CA280097 · NCI · UNIVERSITY OF NOTRE DAME · PI Xin Lu · 2023 to 2026
$1.4M
NCI NIH HHS R01 CA248033NCI NIH HHS R01 CA280097
6 · The paper itself

Abstract

Prostate cancer is a leading cause of cancer-related mortality in men. While early-stage disease is readily treated, advanced-stage prostate cancer has a poor survival rate and limited effective therapies. Immunotherapy has achieved significant success in other malignancies, but prostate cancer is characterized by an immunosuppressive, "cold" tumor microenvironment that blunts immunotherapy efficacy. Emerging evidence suggests that dietary interventions - such as ketogenic diets, methionine restriction, and bioactive compounds like white button mushroom extract - can modulate the tumor microenvironment and enhance immunotherapy responses in preclinical and early clinical studies. Additionally, specific diet-derived factors (such as the ketone body β-hydroxybutyrate) have demonstrated anti-tumor immune effects on their own, representing new avenues for combination therapy. While prior reviews have addressed diet or immunotherapy in prostate cancer independently, this review integrates these domains with the aim of offering a streamlined perspective. This brief review synthesizes recent findings on dietary modulation of prostate cancer immunity, with a focus on mechanistic insights that may be leveraged to augment immunotherapy, to suggest potential combination strategies and inform future translational efforts.

Indexed as

DietImmunotherapyProstatic NeoplasmsAnimalsDiet, KetogenicHumansMaleTumor Microenvironmentcancer metabolismdietary interventionsimmune checkpoint blockadeimmunotherapyketogenic dietnutritional immunologyProstate cancertumor microenvironment

Identifiers

PMID40437998
PMCPMC12506738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.